Date Filed | Type | Description |
12/28/2022 |
4
| Thompson Matthew (Director) has filed a Form 4 on Vivos Therapeutics, Inc.
Txns:
| Granted 30,000 options to buy
@ $0.48, valued at
$14.4k
|
|
08/10/2021 |
4
| Thompson Matthew (Director) has filed a Form 4 on Vivos Therapeutics, Inc.
Txns:
| Granted 30,000 options to buy
@ $2.72, valued at
$81.6k
|
|
12/10/2020 |
3
| Thompson Matthew (Director) has filed a Form 3 on Vivos Therapeutics, Inc. |
08/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/01/2019 |
4
| Thompson Matthew (Chief Medical Officer) has filed a Form 4 on ENDOLOGIX INC /DE/
Txns:
| Disposed/sold 8,999 options to buy
@ $48.2, valued at
$433.8k
Disposed/sold 9,907 options to buy
@ $69.1, valued at
$684.6k
Granted 6,304 options to buy
@ $4.71, valued at
$29.7k
|
|
08/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/10/2019 |
4
| Thompson Matthew (Chief Medical Officer) has filed a Form 4 on ENDOLOGIX INC /DE/
Txns:
| Granted 1,250 shares
@ $0 Paid exercise price by delivering 421 shares
@ $6.4, valued at
$2.7k
|
|
02/01/2019 |
4
| Thompson Matthew (Chief Medical Officer) has filed a Form 4 on ENDOLOGIX INC /DE/
Txns:
| Granted 19,142 shares
@ $0 |
|
01/02/2019 |
4
| Thompson Matthew (Chief Medical Officer) has filed a Form 4 on ENDOLOGIX INC /DE/
Txns:
| Disposed/sold 15,000 shares
@ $0 Granted 470,115 shares
@ $0 Granted 225,621 options to buy
@ $0.7445, valued at
$168k
|
|
06/01/2018 |
4
| Thompson Matthew (Chief Medical Officer) has filed a Form 4 on ENDOLOGIX INC /DE/
Txns:
| Granted 31,000 shares
@ $0 Paid exercise price by delivering 10,719 shares
@ $4.87, valued at
$52.2k
|
|
06/01/2018 |
3
| Thompson Matthew (Chief Medical Officer) has filed a Form 3 on ENDOLOGIX INC /DE/ |